Literature DB >> 21078907

Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.

Robin Mihrshahi1, Marion H Brown.   

Abstract

The CD200 receptor (CD200R) negatively regulates myeloid cells by interacting with its widely expressed ligand CD200. CD200R signals through a unique inhibitory pathway involving a direct interaction with the adaptor protein downstream of tyrosine kinase 2 (Dok2) and the subsequent recruitment and activation of Ras GTPase-activating protein (RasGAP). Ligand engagement of CD200R also results in tyrosine phosphorylation of Dok1, but this protein is not essential for inhibitory CD200R signaling in human myeloid cells. In this paper, we show that CD200R-induced phosphorylation of Dok2 precedes phosphorylation of Dok1, and that Dok2 and Dok1 recruit different downstream proteins. Compared with Dok2, Dok1 recruits substantially less RasGAP. In addition to binding RasGAP, Dok2 recruits the adaptor molecule Nck in response to ligand engagement of CD200R. CD200R-induced phosphorylation of Dok1 results in the recruitment of CT10 sarcoma oncogene cellular homologue-like (CrkL), whereas the closely related CT10 sarcoma oncogene cellular homologue interacts constitutively with Dok1. Knockdown of Dok1 or CrkL expression in U937 cells resulted in increased Dok2 phosphorylation and RasGAP recruitment to Dok2. These data are consistent with a model in which Dok1 negatively regulates Dok2-mediated CD200R signaling through the recruitment of CrkL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078907      PMCID: PMC2999833          DOI: 10.4049/jimmunol.1002858

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  The Nck family of adapter proteins: regulators of actin cytoskeleton.

Authors:  László Buday; Livius Wunderlich; Peter Tamás
Journal:  Cell Signal       Date:  2002-09       Impact factor: 4.315

2.  Down-regulation of the macrophage lineage through interaction with OX2 (CD200).

Authors:  R M Hoek; S R Ruuls; C A Murphy; G J Wright; R Goddard; S M Zurawski; B Blom; M E Homola; W J Streit; M H Brown; A N Barclay; J D Sedgwick
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

3.  CD200 as a prognostic factor in acute myeloid leukaemia.

Authors:  A Tonks; R Hills; P White; B Rosie; K I Mills; A K Burnett; R L Darley
Journal:  Leukemia       Date:  2007-01-25       Impact factor: 11.528

4.  Regulation of myeloid cell function through the CD200 receptor.

Authors:  Maria C Jenmalm; Holly Cherwinski; Edward P Bowman; Joseph H Phillips; Jonathon D Sedgwick
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 5.  The roles of Dok family adapters in immunoreceptor signaling.

Authors:  Ryuichi Mashima; Yukihiro Hishida; Tohru Tezuka; Yuji Yamanashi
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

6.  Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI).

Authors:  W T Kyono; R de Jong; R K Park; Y Liu; N Heisterkamp; J Groffen; D L Durden
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

7.  Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt.

Authors:  M J Wick; L Q Dong; D Hu; P Langlais; F Liu
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

8.  Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation.

Authors:  Shuli Zhang; Joseph H Phillips
Journal:  J Leukoc Biol       Date:  2005-12-05       Impact factor: 4.962

9.  Association of p21ras with phosphatidylinositol 3-kinase.

Authors:  A Sjölander; K Yamamoto; B E Huber; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

Authors:  Gavin J Wright; Holly Cherwinski; Mildred Foster-Cuevas; Gary Brooke; Michael J Puklavec; Mike Bigler; Yaoli Song; Maria Jenmalm; Dan Gorman; Terri McClanahan; Man-Ru Liu; Marion H Brown; Jonathon D Sedgwick; Joseph H Phillips; A Neil Barclay
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

View more
  32 in total

1.  Cytomegalovirus e127 protein interacts with the inhibitory CD200 receptor.

Authors:  Mildred Foster-Cuevas; Tina Westerholt; Mohamed Ahmed; Marion H Brown; A Neil Barclay; Sebastian Voigt
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

Review 2.  Building and Regenerating the Lung Cell by Cell.

Authors:  Jeffrey A Whitsett; Tanya V Kalin; Yan Xu; Vladimir V Kalinichenko
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

3.  Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML).

Authors:  E Coppin; V Gelsi-Boyer; X Morelli; N Cervera; A Murati; P P Pandolfi; D Birnbaum; J A Nunès
Journal:  Leukemia       Date:  2014-09-25       Impact factor: 11.528

Review 4.  Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles.

Authors:  Xiaoming Hu; Anthony K F Liou; Rehana K Leak; Mingyue Xu; Chengrui An; Jun Suenaga; Yejie Shi; Yanqin Gao; Ping Zheng; Jun Chen
Journal:  Prog Neurobiol       Date:  2014-06-09       Impact factor: 11.685

Review 5.  CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy.

Authors:  Jin-Qing Liu; Aiyan Hu; Jianmin Zhu; Jianyu Yu; Fatemeh Talebian; Xue-Feng Bai
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand.

Authors:  Merav Cohen; Hila Ben-Yehuda; Ziv Porat; Catarina Raposo; Siamon Gordon; Michal Schwartz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

7.  Anti-inflammation conferred by stimulation of CD200R1 via Dok1 pathway in rat microglia after germinal matrix hemorrhage.

Authors:  Zhanhui Feng; Lan Ye; Damon Klebe; Yan Ding; Zhen-Ni Guo; Jerry J Flores; Cheng Yin; Jiping Tang; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-09       Impact factor: 6.200

8.  Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200.

Authors:  Karen Misstear; Simon A Chanas; S A Rahim Rezaee; Rachel Colman; Laura L Quinn; Heather M Long; Oliver Goodyear; Janet M Lord; Andrew D Hislop; David J Blackbourn
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

9.  Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?

Authors:  Douglas G Walker; Lih-Fen Lue
Journal:  Future Neurol       Date:  2013-05

Review 10.  Macrophages and the Recovery from Acute and Chronic Inflammation.

Authors:  Kajal Hamidzadeh; Stephen M Christensen; Elizabeth Dalby; Prabha Chandrasekaran; David M Mosser
Journal:  Annu Rev Physiol       Date:  2016-12-07       Impact factor: 19.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.